VanEck Associates’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$793K Buy
49,547
+14,111
+40% +$226K ﹤0.01% 1094
2025
Q1
$689K Buy
35,436
+6,448
+22% +$125K ﹤0.01% 1101
2024
Q4
$639K Buy
+28,988
New +$639K ﹤0.01% 1104